NL300884I2 - Ozenoxacin - Google Patents

Ozenoxacin

Info

Publication number
NL300884I2
NL300884I2 NL300884C NL300884C NL300884I2 NL 300884 I2 NL300884 I2 NL 300884I2 NL 300884 C NL300884 C NL 300884C NL 300884 C NL300884 C NL 300884C NL 300884 I2 NL300884 I2 NL 300884I2
Authority
NL
Netherlands
Prior art keywords
ozenoxacin
Prior art date
Application number
NL300884C
Other languages
English (en)
Dutch (nl)
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40291273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300884(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NL300884I2 publication Critical patent/NL300884I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL300884C 2008-10-17 2017-07-11 Ozenoxacin NL300884I2 (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08166933A EP2177208A1 (en) 2008-10-17 2008-10-17 Pharmaceutical topical compositions
EP09736946.6A EP2344130B9 (en) 2008-10-17 2009-10-16 Pharmaceutical topical compositions
PCT/EP2009/063625 WO2010043717A2 (en) 2008-10-17 2009-10-16 Pharmaceutical topical compositions

Publications (1)

Publication Number Publication Date
NL300884I2 true NL300884I2 (nl) 2017-08-31

Family

ID=40291273

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300884C NL300884I2 (nl) 2008-10-17 2017-07-11 Ozenoxacin

Country Status (23)

Country Link
US (4) US9180200B2 (enExample)
EP (3) EP2177208A1 (enExample)
JP (2) JP5509209B2 (enExample)
KR (3) KR101682256B1 (enExample)
CN (1) CN102186460B (enExample)
AR (1) AR073901A1 (enExample)
AU (1) AU2009305360B2 (enExample)
BR (1) BRPI0920355B8 (enExample)
CA (2) CA2738384C (enExample)
CL (2) CL2011000848A1 (enExample)
CY (1) CY1114838T1 (enExample)
DK (1) DK2344130T3 (enExample)
ES (1) ES2437967T3 (enExample)
MX (2) MX2011004052A (enExample)
NL (1) NL300884I2 (enExample)
PH (1) PH12014502425A1 (enExample)
PL (1) PL2344130T3 (enExample)
PT (1) PT2344130E (enExample)
RU (1) RU2478367C2 (enExample)
SI (1) SI2344130T1 (enExample)
TW (2) TWI504418B (enExample)
UY (1) UY32187A (enExample)
WO (1) WO2010043717A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130070608A (ko) 2010-05-10 2013-06-27 세게티스, 인코포레이티드. 미립자 고체에 대한 분산제 및 슬립제로서의 알킬 케탈 에스터 및 그의 제조방법, 및 용도
WO2014047428A1 (en) 2012-09-21 2014-03-27 Segetis, Inc. Cleaning, surfactant, and personal care compositions
DE102013226507B4 (de) * 2013-12-18 2022-05-05 Ashland Industries Europe Gmbh Konzentrat umfassend Ferulasäureethylester und Arylalkanol und dessen Verwendung
ES2661000T3 (es) * 2014-09-12 2018-03-27 Antibiotx A/S Uso antibacteriano de salicilanilidas halogenadas
EP3257512A4 (en) * 2015-02-13 2018-07-25 Maruho Co., Ltd. External preparation comprising pyridonecarboxylic acid derivative
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
GB201604484D0 (en) 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
JP7347915B2 (ja) * 2016-04-28 2023-09-20 マルホ株式会社 抗菌剤
WO2018048042A1 (ko) * 2016-09-12 2018-03-15 주식회사 가나씨앤에이치 글리세린 젖산 에스테르를 유효성분으로 하는 방부 및 항균용 외용제 조성물
EP3549586A1 (en) * 2016-12-01 2019-10-09 Maruho Co., Ltd. Medical skin external preparation
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide
CN113712913A (zh) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 一种奥泽沙星混悬滴眼液组合物
US11724077B2 (en) * 2021-07-28 2023-08-15 Subhash Dhawan Therapeutic swabs for treating upper respiratory infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04243827A (ja) * 1991-01-25 1992-08-31 Sumitomo Pharmaceut Co Ltd プロスタグランジン誘導体含有溶解型軟膏剤
JP3174590B2 (ja) * 1991-04-04 2001-06-11 テルモ株式会社 ステロイド軟膏剤
FR2728166A1 (fr) * 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
JP3162335B2 (ja) * 1998-03-11 2001-04-25 ユーナイテッド ネイションズ デベロップメント プログラム 皮膚真菌感染症治療用の植物薬剤、その製造法と用途
ATE342897T1 (de) 1998-04-06 2006-11-15 Toyama Chemical Co Ltd Chinoloncarbonsäurederivate oder deren salze
GB0013674D0 (en) * 1999-06-08 2000-07-26 Lorantis Ltd Therapeutic use
JP4293755B2 (ja) 2001-03-26 2009-07-08 富山化学工業株式会社 ピリドンカルボン酸系化合物を含有する皮膚外用剤
JP4384402B2 (ja) 2001-11-30 2009-12-16 富山化学工業株式会社 デスフルオロピリドンカルボン酸系化合物を含有する水溶液剤およびその粉末化物並びにそれら製造方法
PL1731138T3 (pl) 2004-03-31 2016-10-31 Drobnoziarnista dyspersja słabo rozpuszczalnego leku i sposób jej wytwarzania
EP1698336A1 (en) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
ES2553179T3 (es) 2005-08-01 2015-12-04 Maruho Co., Ltd. Preparación de una loción que contiene un derivado del ácido piridoncarboxílico
JP5112669B2 (ja) 2005-09-30 2013-01-09 富山化学工業株式会社 難溶性薬物のナノ微粒子を含有する水性懸濁液剤

Also Published As

Publication number Publication date
US10022363B2 (en) 2018-07-17
UY32187A (es) 2010-04-30
CN102186460A (zh) 2011-09-14
CA2738384C (en) 2014-07-08
KR20160025034A (ko) 2016-03-07
EP2344130A2 (en) 2011-07-20
TW201511779A (zh) 2015-04-01
JP5509209B2 (ja) 2014-06-04
KR20160116353A (ko) 2016-10-07
RU2478367C2 (ru) 2013-04-10
PL2344130T3 (pl) 2014-03-31
US9180200B2 (en) 2015-11-10
ES2437967T3 (es) 2014-01-15
AU2009305360B2 (en) 2015-04-09
SI2344130T1 (sl) 2013-12-31
JP5873120B2 (ja) 2016-03-01
CY1114838T1 (el) 2016-12-14
WO2010043717A3 (en) 2010-07-29
KR20110071086A (ko) 2011-06-28
TWI504418B (zh) 2015-10-21
US20110263646A1 (en) 2011-10-27
BRPI0920355B1 (pt) 2020-04-07
AU2009305360A1 (en) 2010-04-22
US20160030338A1 (en) 2016-02-04
MX338029B (es) 2016-03-31
US9399014B2 (en) 2016-07-26
EP2177208A1 (en) 2010-04-21
BRPI0920355A2 (pt) 2016-03-15
CL2011000848A1 (es) 2012-03-30
RU2011119764A (ru) 2012-11-27
US20160243104A1 (en) 2016-08-25
MX2011004052A (es) 2011-05-10
AR073901A1 (es) 2010-12-09
HK1161552A1 (en) 2012-07-27
CN102186460B (zh) 2013-06-12
US20140187578A1 (en) 2014-07-03
EP2344130B9 (en) 2013-11-20
PT2344130E (pt) 2013-12-09
CL2015002899A1 (es) 2016-05-13
KR101682256B1 (ko) 2016-12-02
TW201018497A (en) 2010-05-16
CA2822167A1 (en) 2010-04-22
CA2738384A1 (en) 2010-04-22
BRPI0920355B8 (pt) 2021-05-25
JP2012505867A (ja) 2012-03-08
CA2822167C (en) 2015-09-01
PH12014502425A1 (en) 2015-09-07
EP2570117A1 (en) 2013-03-20
EP2344130B1 (en) 2013-09-04
WO2010043717A2 (en) 2010-04-22
DK2344130T3 (da) 2013-12-09
JP2014088456A (ja) 2014-05-15

Similar Documents

Publication Publication Date Title
NL300965I1 (nl) Patisiran
DE602009000234D1 (de) msignals
DK3444343T3 (da) Polypeptider
EP2368526A4 (en) INSERTION TOOL FOR AN INTRAOCULAR LENS
EP2336764A4 (en) FLÜSSIGCHROMATOGRAF
BRPI0914649A2 (pt) Piprazolo-quinazolinas
DE602008003972D1 (de) Sitzrücklehnungsmechanismus
DE602008003521D1 (de) Sitzrücklehnungsmechanismus
DK2342454T3 (da) Vindkraftanlæg
DK2336132T3 (da) Morpholinpurinderivat
EP2368115A4 (en) ANALYTE DETECTION TEST
DK2335031T3 (da) In-line-måler
EP2308156A4 (en) STEP ACTUATOR
DE602008003970D1 (de) Strahlstromkalibriersystem
BRPI0907522A2 (pt) biarlamidas
EP2318641A4 (en) BOHRROHRZENTRIERER
EP2248964A4 (en) DRILLING / TERMINAL DEVICE
DE112009000183A5 (de) Sicherheitsvorreiber
EP2339366A4 (en) DEVICE FOR OPTICAL DISTANCE MEASUREMENT
EP2261152A4 (en) REEL
BRPI0909634A2 (pt) 2-aminoquinolinas
DE602009000862D1 (de) Gehwagenbremse
DE602009000488D1 (de) Obstvereinzelvorrichtung
BRPI0907863A2 (pt) pirrolopirimidinacarboxamidas
BRPI0909637A2 (pt) 2-aminoquinolinas